Related by context. Frequent words. (Click for all words.) 67 Initiates Phase II 66 GVAX R 66 R sorafenib tablets 66 Phase IIa clinical trials 66 TRANSDUR Sufentanil 65 AQ4N 65 pradefovir 65 TELINTRA 64 Panzem R 64 Entereg R 64 Takeda Kyowa Hakko Kirin 64 NASDAQ LGND 63 Completes Enrollment 63 Nasdaq ENMD 63 Receives Orphan Drug Designation 63 PLK1 SNALP 63 Pharmion Corporation 63 Presents Positive 63 eprodisate KIACTA TM 63 inflammatory autoimmune diseases 63 topical anti infective 62 Shigamabs ® 62 Inc Therapeutic Competitors 62 Altus Pharmaceuticals 62 elotuzumab 62 AzaSite Plus 62 NV Organon 62 SAR# [004] 62 Nasdaq OSIP 62 squalamine 62 ZEGERID Capsules 62 Asentar 62 Files Shelf Registration Statement 62 BioGlue R 62 Inc. Nasdaq IMGN 62 Genitope Corporation 61 Advancing Drugs 61 JAK inhibitor 61 Argatroban 61 Transcept Pharmaceuticals 61 Pivotal Phase III 61 Inc. Nasdaq TRMS 61 danoprevir 61 Inc. Nasdaq VVUS 61 DRRX 61 Commercialization Agreement 61 vernakalant oral 61 CDP# 61 Inc. NASDAQ QLTI 61 Soliris TM eculizumab 61 vosaroxin 61 TOCOSOL Paclitaxel 61 Harbor BioSciences 61 Meets Primary Endpoint 61 please visit http:/www.supergen.com 60 refractory chronic lymphocytic 60 Initiates Phase 60 Actimmune R 60 PEG SN# 60 oral calcitonin 60 addressing idiopathic pulmonary 60 FavId 60 PEG PAL PEGylated recombinant 60 Belinostat 60 Initiate Phase 60 developing Zerenex TM 60 Eligard ® 60 Rosetta dependence 60 Nasdaq VRTX 60 ZALBIN 60 Xyntha 60 ELADUR 60 Prestara 60 Copegus R 60 confirmatory Phase III 60 NASDAQ CRXL 60 Palatin Technologies Inc. 60 Onalta 60 Omigard 59 AZX# 59 phase IIb clinical 59 Pivotal Phase 59 Therapeutic Competitors 59 Eloxatin ® 59 Eligard R 59 Sunesis Pharmaceuticals 59 BiTE R 59 THALOMID 59 Kuvan R 59 phenylalanine ammonia lyase 59 Daclizumab 59 Hybridon 59 EPIX Pharmaceuticals 59 valopicitabine 59 NEBIDO R 59 Allovectin 7 R 59 EntreMed Inc. 59 Dynepo 59 gets USFDA nod 59 MKC# 59 Inc. Nasdaq SGEN